1Sigel JE, Bergfeld WF, Goldblum JR. A morphologic study of dermatofibrosarcoma protuberans: expansion of a histologic profile. Journal of Cutaneous Pathology, 2000,27(4): 159 - 163.
2Goldblum JR, Tuthill RJ. CD34 and Factor- XⅢa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.The American Journal of Dermatopathology, 1997, 19(2) : 147-153.
3Goldblam JR. Giant cell fibroblastoma, dermatofibrosarcoma protuberans, and fibrosarcomatous change. Pathology Case Reviews, 2002, 7(4): 127-132.
4Alam M, Husain S, Ratner D. Discussion of questions 21 - 30[Self- assessment: answers to self- assessment examination of the american academy of dermatology]. Journal of the American Academy of Dermatology, 2001, 45(3 (Part 1)): 486.
5Eduardo C, Christopher F. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatousvariant: clinicopathologic analysis of 5 cases. Journal of Cutaneous Pathology,1996, 23 (1):30-36.
6Manabul S, Tsuyoshi I, Hajime H, et al. Dermatofibrosarcoma protuberans: An analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression. Pathology International, 1999, 49(9): 799-806.
7Hisaoka M, Okamoto S, Morimitsu Y, et al. Dermatofibrosarcoma protuberans with fibrosarcomatous areas molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Virchows Arch, 1998,433: 323- 329.
8Augusto O, Luca B, Giusto SL. Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features. Journal of Cutaneous Pathology, 1998, 25 (7):386 - 393.
9Roberto B, Elena I, Carlo C. Unusual features of primary dermatofibrosarcoma protuberans and its myxoid recurrence. Journal of Cutaneous Pathology, 1996, 23(3): 283- 287.
10Maire G, Pedeutour F, Coindre JM. COL1A1 - PDGFB gene fusion demonstrates a common histogenetic origin for dermatofibrosarcoma protuberans and its granular cell variant. The American Journal of Surgical Pathology, 2002, 26(7): 932 -937.
4Breuninger H, Sebastian G, Garbe C. Dermatoflbrosarcoma protuberans-an update [ J ]. J Dtsch Dermatol Ges,2004,2 ( 8 ) :661-667.
5Elgart GW, Hanly A. Bednar tumor occurring in a site of prior immuniza- tion : Immunochemieal findings and therapy [ J ]. J Am Aead Dermatol, 1999,40(2) :315-317.
6Gooskens SL, Oranje AP, Van Adrichem LN, et al. Imatinib mesylate for children with dermatofibrosareoma [ J ]. Pediatr Blood Cancer, 2010,55 (2) :369-373.
7Alam M, Husain S, Ratner D. Discussion of question 21-30 [ J ]. J Am Acad Dermato1,2001,45 (4) :486.
8Goldblum JR. Giant cell fibroblasroma, dermatofibrosarcoma protuberans, and fibrosarcomatous change [ J ]. Pathology Case Review, 2002,7 ( 4 ) : 127-132.
